ACO Population Definitions

Lead Investigators:

  • Jerry Krishnan: Population Health Sciences Program, University of Illinois Hospital and Health Sciences System, Chicago, IL, USA, and Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.
  • Nicolas Roche: Pneumologie et soins intensifs respiratoires, groupe hospitalier Cochin – site Val-de-Grâce, Assistance publique-Hôpitaux de Paris, 75014 Boulogne, France; EA2511, Université Paris Descartes, 75006 Paris, France

Research Team

  • David Price: Primary Care Respiratory Medicine, University of Aberdeen, Aberdeen, UK; Owner of Optimum Patient Care Ltd and REG Chairman
  • Victoria Carter: General Manager of Optimum Patient Care Ltd
  • Janwillem Kocks: Department of General Practice, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  • Marc Miravitlles: Pneumology Department, University Hospital Vall d’Hebron, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain
  • Mark Small: Project Director, Adelphi Real World, Stockport, UK
  • James Bailey: Project Manager, Adelphi Real World, Stockport, UK
  • Miguel Román: Primary Care Majorca Department, Son Pisà Primary Health Centre, C/ Vicenç Joan Perello Ribes, 65, Palma de Mallorca, Baleares, Spain
  • Job van Boven: Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands
  • Alan Kaplan: Family Physician Airways Group of Canada, Warwick, Canada
  • Akki Niimi: Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • Claus Vogelmeier: Department of Internal Medicine, Division for Pulmonary Diseases, Hospital of the University of Giessen and Marburg, Marburg, Germany
  • Dirkje Postma: Department of Pulmonology, University Medical Center, Hanzeplein 1 AA11, Groningen, the Netherlands
  • Eric Bateman: Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa
  • Emilio Pizzichini: Federal University of Santa Catarina, Department of Internal Medicine, NUPAIVA Research Group, University Hospital, Florianopolis, Santa Catarina, Brazil
  • Eric van Ganse: Lyon Pharmaco-Epidemiology Unit- UMR 5558 CNRS-Claude Bernard Lyon 1 University, Lyon, France [2] Respiratory Medicine, Croix-Rousse University Hospital, Lyon, France
  • Guy Brusselle: Department of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium ; Department of Epidemiology, Erasmus Medical Center, Rotterdam, Netherlands ; Department of Respiratory Medicine, Erasmus Medical Center, Rotterdam, Netherlands
  • Leif Bjermer: Department of Respiratory Medicine and Allergology, University Hospital, Lund, Sweden
  • Ronald Dandurand: Montreal Chest Institute & Meakins-Christie Laboratories, McGill University, Montreal, QC, Canada
  • Richard Costello: Department of Respiratory Medicine, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin, Ireland
  • Richard Martin: Department of Medicine, National Jewish Health, Denver, Colorado, USA
  • Alison Chisholm: Chief Scientific Officer of REG, Cambridge, UK

Status: Planned, seeking funding

Short Description:

The study aims to inform standardised methods for future ACOS observational research, the study aims to: test various smoking-related ACOS population definitions (based on previous evidence), evaluating their respective prevalence and agreement (i) within and (ii) between a number of Western research-quality databases.

Documents and Publications”




Final Publications

Additional Material